View Item 

Show simple item record

The Role of Chemokines in Oral Tolerance.

dc.contributor.authorKarpus, William J.en_US
dc.contributor.authorLukacs, Nicholas W.en_US
dc.date.accessioned2010-06-01T22:34:27Z
dc.date.available2010-06-01T22:34:27Z
dc.date.issued1996-02en_US
dc.identifier.citationKARPUS, WILLIAM J.; LUKACS, NICHOLAS W. (1996). "The Role of Chemokines in Oral Tolerance.." Annals of the New York Academy of Sciences 778(1): 133-144. <http://hdl.handle.net/2027.42/75554>en_US
dc.identifier.issn0077-8923en_US
dc.identifier.issn1749-6632en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/75554
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=8610967&dopt=citationen_US
dc.format.extent645660 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rights1996 The New York Academy of Sciencesen_US
dc.titleThe Role of Chemokines in Oral Tolerance.en_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelScience (General)en_US
dc.subject.hlbtoplevelScienceen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Pathology University of Michigan Medical School Ann Arbor, Michiganen_US
dc.contributor.affiliationotherDepartment of Microbiology and Immunology Northwestern University Medical School 303 Chicago Avenue, 6-721 Tarry Building Chicago, Illinois 60611en_US
dc.identifier.pmid8610967en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/75554/1/j.1749-6632.1996.tb21122.x.pdf
dc.identifier.doi10.1111/j.1749-6632.1996.tb21122.xen_US
dc.identifier.sourceAnnals of the New York Academy of Sciencesen_US
dc.identifier.citedreferenceWeiner, H. L. 1994. Oral tolerance. Proc. Natl. Acad. Sci. USA 91: 10762 – 10765.en_US
dc.identifier.citedreferenceLDER, O., L. M. SANTOS, C. S. LEE, P. J. HIGGINS, L H. L. WEINER. 1989. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. II. Suppression of hsease and in vitro immune responses is mediated by antigen-specific CD8+ T lymphocytes. J. Immunol. 142: 748 – 752.en_US
dc.identifier.citedreferenceBITAR, D. M. & C. C. WHITACRE. 1988. Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein. Cell. Immunol. 112: 364 – 370.en_US
dc.identifier.citedreferenceNWSSFNBLATT, R. B., R. R. CASPI, R. MAHDI, C.-C. CHAN, F. ROBERGE, O. LIDEK & H. L. WEINER. 1990. Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen. I. Immunol. 144: 1689 – 1695.en_US
dc.identifier.citedreferenceZHANG, Z. Y., C. S. LEE, O. LIDER & H. L. WEINER. 1990. Suppression of adjuvant arthritis in Lewis rats by oral administration of type II collagen. J. Immunol. 145: 2489 – 2493.en_US
dc.identifier.citedreferenceWANG, Z.-Y., J. HUANG, T. OLSSON, B. HE & H. LINK. 1995. B cell responses to acetylcholine receptor in rats orally tolerized against experimental autoimmune myasthenia gravis. J. Neurol. Sci. 128: 167 – 174.en_US
dc.identifier.citedreferenceWEINFR, H. L., G. A. MACKIN, M. MATSUI, E. J. ORAV, S. J. KHOURY, D. M. DAWSON & D. A. HAFUR. 1993. Double-blind pilot trial of oral tolerance with myelin antigens in multiple sclerosis. Science 259: 1321 – 1323.en_US
dc.identifier.citedreferenceTRENTHAM, D. E., R. A. DYNESRTS-TRENTHAM, E. J. ORAV, D. COMBITCHI, C. LORENZO, K. L. SEWELL, D. A. HAFLEX & H. L. WEINER. 1993. Effects of oral administration of type II collagen on rheumatoid arthritis Science 261: 1727 – 1730.en_US
dc.identifier.citedreferenceMILLER, S. D. & D. G. HANSON. 1979. Inhlbition of specific immune responses by feeding protein antigens. IV. Evidence for tolerance and specific active suppression of mediated immune responses to ovalbumin. J. Immunol. 123: 2344 – 2350.en_US
dc.identifier.citedreferenceHANSON, D. G. & S. D. MILLER. 1982. Inhibition of specific immune responses by feeding protein antigens. V. Induction of the tolerant state in the absence of specific suppressor cells. J. Immunol. 128: 2378 – 2381.en_US
dc.identifier.citedreferenceASHERSON, G. L., M. ZEMBALA, M. A. C. C. PERERA, B. MAYHEW & W. R. THOMAS. 1977. Production of immunity and unresponsiveness in the mouse by feeding contact sensitizing agents and the role of suppressor cells in the Peyer's patches, mesenteric lymph nodes and other lymphoid tissues. Cell. Immunol. 33: 145 – 155.en_US
dc.identifier.citedreferenceStrobel, S., A. M. Mowat, H. E. Drummond, M. G. Pickering & A. Ferguson. 1983. Immunological responses to fed protein antigens in mice. Oral tolerance for CMI is due to activation of cyclophosphamide-sensitive cells by gut-processed antigen. Immunology 49: 451 – 456.en_US
dc.identifier.citedreferenceRichman, L. K., J. M. Chiller, W. R. Brown, D. G. Hanson & N. M. Vaz. 1978. Enterically induced immunologic tolerance. I. Induction of suppressor T lymphocytes by intragastric administration of soluble proteins. J. Immunol. 121: 2429 – 2434.en_US
dc.identifier.citedreferenceWhitacre, C. C., I. E. Gienapp, C. G. Orosz & D. M. Bitar. 1991. Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy. J. Immunol. 147: 2155 – 2163.en_US
dc.identifier.citedreferenceMiller, A., O. Lider, A. B. Roberts, M. B. Sporn & H. L. Weiner. 1992. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor Β after antigen-specific triggering. Proc. Natl. Acad. Sci. USA 89: 421 – 425.en_US
dc.identifier.citedreferenceFriedman, A. & H. L. Weiner. 1994. Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc. Natl. Acad. Sci. USA 91: 6688 – 6692.en_US
dc.identifier.citedreferenceKay, R. A. & A. Ferguson. 1989. The immunological consequences of feeding cholera toxin. II. Mechanisms responsible for the induction of oral tolerance for DTH. Immunology 66: 416 – 421.en_US
dc.identifier.citedreferenceMichalek, S. M., J. R. McGhee, H. Kiyono, D. E. Colwell, J. H. Eldridge, M. J. Wannemuehler & W. J. Koopman. 1983. The IgA response: Inductive aspects, regulatory cells, and effector functions. Ann. N.Y. Acad. Sci. 409: 48 – 71.en_US
dc.identifier.citedreferenceEnomoto, A., M. Konishi, S. Hachimura & S. Kaminogawa. 1993. Milk whey protein fed as a constituent of the diet induced both oral tolerance and a systemic humoral response, while heat-denatured whey protein induced only oral tolerance. Clin. Immunol. Immunopathol. 66: 136 – 142.en_US
dc.identifier.citedreferenceHusby, S., J. Mestecky, Z. Moldoveanu, S. Holland & C. O. Elson. 1994. Oral tolerance in humans. T cell but not B cell tolerance after antigen feeding. J. Immunol. 152: 4663 – 4670.en_US
dc.identifier.citedreferenceElson, C. O. & W. Ealding. 1984. Cholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated protein antigen. J. Immunol. 133: 2892 – 2897.en_US
dc.identifier.citedreferenceFaria, A. M., G. Garcia, M. J. Rios, C. L. Michalaros & N. M. Vaz. 1993. Decrease in susceptibility to oral tolerance induction and occurrence of oral immunization to ovalbumin in 20- to 38-week-old mice. The effect of interval between oral exposures and rate of antigen intake in the oral immunization. Immunology 78: 147 – 151.en_US
dc.identifier.citedreferenceHanson, D. G., M. J. Roy, G. M. Green & S. D. Miller. 1993. Inhibition of orally-induced immune tolerance in mice by prefeeding an endopeptidase inhibitor. Reg. Immunol. 5: 85 – 93.en_US
dc.identifier.citedreferenceMichalek, S. M., H. Kiyono, M. J. Wannemuehler, L. M. Mosteller & J. R. McGhee. 1982. Lipopolysaccharide (LPS) regulation of the immune response: LPS influence on oral tolerance induction. J. Immunol. 128: 1992 – 1998.en_US
dc.identifier.citedreferenceRussel, G. & C. Costalos. 1980. Oral tolerance of Caloreen in babies. Arch. Dis. Child. 55: 886 – 887.en_US
dc.identifier.citedreferenceDomen, P. L., A. Muckerheide & J. G. Michael. 1987. Cationization of protein antigens. III. Abrogation of oral tolerance. J. Immunol. 139: 3195 – 3198.en_US
dc.identifier.citedreferenceSun, J.-B., J. Holmgren & C. Czerkinsky. 1994. Cholera toxin B subunit: An efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance. Proc. Natl. Acad. Sci. USA 91: 10795 – 10799.en_US
dc.identifier.citedreferenceVajdy, M., M. H. Kosco-Vilbois, M. Kopf, G. KÖhler & N. Lycke. 1995. Impaired mucosal immune responses in interleukin 4-targeted mice. J. Exp. Med. 181: 41 – 53.en_US
dc.identifier.citedreferenceSuzuki, I., H. Kiyono, K. Kitamura, D. R. Green & J. R. McGhee. 1986. Abrogation of oral tolerance by contrasuppressor T cells suggests the presence of regulatory T-cell networks in the mucosal immune system. Nature 320: 451 – 454.en_US
dc.identifier.citedreferenceSuh, E. D., B. P. Vistica, C. C. Chan, J. M. Raber, I. Gery & R. B. Nussenblatt. 1993. Splenectomy abrogates the induction of oral tolerance in experimental autoimmune uveoretinitis. Curr. Eye Res. 12: 833 – 839.en_US
dc.identifier.citedreferenceSchall, T. J. 1991. Biology of the RANTES/SIS cytokine family. Cytokine 3: 165 – 183.en_US
dc.identifier.citedreferenceMiller, M. D. & M. S. Krangel. 1992. Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines. Crit. Rev. Immunol. 12: 17 – 46.en_US
dc.identifier.citedreferenceOppenheim, J. J., C. O. C. Zachariae, N. Mukaida & K. Matsushima. 1991. Properties of the novel proinflammatory supergene “intercrine” cytokine family. Annu. Rev. Immunol. 9: 617 – 648.en_US
dc.identifier.citedreferenceErnst, C. A., Y. J. Zhang, P. R. Hancock, B. J. Rutledge, C. L. Corless & B. J. Rollins. 1994. Biochemical and biologic characterization of murine monocyte chemoattractant protein-1. J. Immunol. 152: 3541 – 3549.en_US
dc.identifier.citedreferenceDavatelis, G., P. Tekamp-Olson, S. D. Wolpe, K. Hermsen, C. Luedke, C. Gallegos, D. Coit, J. Merryweather & A. Cerami. 1988. Cloning and characterization of a cDNA for murine macrophage inflammatory protein (MIP), a novel monokine with inflammatory and chemokine properties. J. Exp. Med. 167: 1939 – 1944.en_US
dc.identifier.citedreferenceLukacs, N. W., S. W. Chensue, R. E. Smith, R. M. Strieter, K. Warmington, C. Wilke & S. L. Kunkel. 1994. Production of monocyte chemoattractant protein-1 and macrophage inflammatory protein-1 alpha by inflammatory granuloma fibroblasts. Am. J. Pathol. 144: 711 – 718.en_US
dc.identifier.citedreferenceButcher, E. C. 1991. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 67: 1033 – 1036.en_US
dc.identifier.citedreferenceSpringer, T. A. 1994. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76: 301 – 314.en_US
dc.identifier.citedreferenceVaddi, K. & R. C. Newton. 1994. Regulation of monocyte integrin expression by Β-family chemokines. J. Immunol. 153: 4721 – 4732.en_US
dc.identifier.citedreferenceTanaka, Y., D. H. Adams, S. Hubscher, H. Hirano, U. Sienbenlist & S. Shaw. 1993. T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1Β. Nature 361: 79 – 82.en_US
dc.identifier.citedreferenceRollins, B. J., E. D. Morriso & C. D. Stiles. 1988. Cloning and expression of JE, a gene inducible by platelet-derived growth factor and whose product has cytokine-like properties. Proc. Natl. Acad. Sci. USA 85: 3738 – 3742.en_US
dc.identifier.citedreferenceVan Damme, J., P. Proost, W. Put, S. Arens, J.-P. Lenaerts, R. Conings, G. Opdenakker, H. Heremans & A. Billiau. 1994. Induction of monocyte chemotactic proteins MCP-1 and MCP-2 in human fibroblasts and leukocytes by cytokines and cytokine inducers. Chemical synthesis of MCP-2 and development of a specific RIA. J. Immunol. 152: 5495 – 5502.en_US
dc.identifier.citedreferenceCarr, M. W., S. J. Roth, E. Luther, S. S. Rose & T. A. Springer. 1994. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc. Natl. Acad. Sci. USA 91: 3652 – 3656.en_US
dc.identifier.citedreferenceLoetscher, P., M. Seitz, I. Clark-Lewis, M. Baggiolini & B. Moser. 1994. Monocyte chemotactic proteins MCP-1, MCP-2, and MCP-3 are major attractants for human CD4 + and CD8 + T lymphocytes. FASEB J. 8: 1055 – 1060.en_US
dc.identifier.citedreferenceJung, H. C., L. Eckmann, S.-K. Yang, A. Panja, J. Fierer, E. Morzycka-Wroblewska & M. F. Kagnoff. 1995. A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J. Clin. Invest. 95: 55 – 65.en_US
dc.identifier.citedreferencePeterson, J. D., W. J. Karpus, R. J. Clatch & S. D. Miller. 1993. Split tolerance of Th1 and Th2 cells in tolerance to Theiler's murine encephalomyelitis virus. Eur. J. Immunol. 23: 46 – 55.en_US
dc.identifier.citedreferenceLukacs, N. W., S. L. Kunkel, R. M. Strieter, K. Warmington & S. W. Chensue. 1993. The role of macrophage inflammatory protein 1Α in Shistosoma mansoni egg-induced granulomatous inflammation. J. Exp. Med. 177: 1551 – 1559.en_US
dc.identifier.citedreferenceKarpus, W. J., J. D. Peterson & S. D. Miller. 1994. Anergy in vivo: down-regulation of antigen-specific CD4 + Th1 but not Th2 cytokine responses. Int. Immunol. 6: 721 – 730.en_US
dc.identifier.citedreferenceChen, Y., V. K. Kuchroo, J. Inobe, D. A. Hafler & H. L. Weiner. 1994. Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis. Science 265: 1237 – 1240.en_US
dc.identifier.citedreferenceTomasi, T. B., Jr. 1980. Oral tolerance. Transplantation 29: 353 – 356.en_US
dc.identifier.citedreferenceWeiner, H. L., A. Friedman, A. Miller, S. J. Khoury, A. Al-Sabbagh, L. Santos, M. Sayegh, R. B. Nussenblatt, D. E. Trentham & D. A. Hafler. 1994. Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu. Rev. Immunol. 12: 809 – 837.en_US
dc.identifier.citedreferenceKarpus, W. J., N. W. Lukacs, B. L. McRae, R. M. Strieter, S. L. Kunkel & S. D. Miller. 1995. An important role for the chemokine macrophage inflammatory protein-1Α in the pathogenesis of the T-cell mediated autoimmune disease, experimental autoimmune encephalomyelitis. J. Immunol. 155: 5003 – 5010.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1749-6632.1996.tb21122.x.pdf
Size:
630.5KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.